Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 4 | Starlite/ChEMBL | No references |
Plasmodium falciparum (isolate 3D7) | Proline--tRNA ligase | Starlite/ChEMBL | No references |
Plasmodium falciparum | calcium-dependent protein kinase 1 | Starlite/ChEMBL | No references |
Plasmodium falciparum | lysine--tRNA ligase | Starlite/ChEMBL | No references |
Plasmodium falciparum | hexose transporter | Starlite/ChEMBL | No references |
Homo sapiens | solute carrier family 2 (facilitated glucose transporter), member 1 | Starlite/ChEMBL | No references |
Plasmodium falciparum | mitogen-activated protein kinase 2 | Starlite/ChEMBL | No references |
Plasmodium falciparum | protein kinase 7 | Starlite/ChEMBL | No references |
Leishmania mexicana | glucose transporter, lmgt2 | Starlite/ChEMBL | No references |
Plasmodium falciparum | protein kinase 6 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Sugar transporter family protein | 0.0018 | 0.0201 | 0.0894 |
Toxoplasma gondii | transporter, major facilitator family protein | 0.0018 | 0.0201 | 0.0305 |
Toxoplasma gondii | facilitative glucose transporter GT1 | 0.0126 | 0.2253 | 0.3408 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Toxoplasma gondii | sugar transporter ST3 | 0.0018 | 0.0201 | 0.0305 |
Schistosoma mansoni | lysyl-tRNA synthetase | 0.0028 | 0.0399 | 0.1769 |
Loa Loa (eye worm) | major facilitator superfamily transporter | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma cruzi | lysyl-tRNA synthetase, putative | 0.0028 | 0.0399 | 0.5689 |
Echinococcus multilocularis | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Echinococcus multilocularis | General substrate transporter | 0.0108 | 0.1918 | 0.851 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Plasmodium falciparum | major facilitator superfamily domain-containing protein, putative | 0.0018 | 0.0201 | 0.0201 |
Plasmodium falciparum | calcium-dependent protein kinase 4 | 0.0039 | 0.0597 | 0.0597 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase type 1 | 0.0039 | 0.0597 | 0.2648 |
Plasmodium vivax | proline--tRNA ligase, putative | 0.0044 | 0.0701 | 0.0701 |
Toxoplasma gondii | cell-cycle-associated protein kinase MAPK, putative | 0.0204 | 0.3724 | 0.5632 |
Plasmodium falciparum | calcium-dependent protein kinase 1 | 0.0039 | 0.0597 | 0.0597 |
Toxoplasma gondii | protein kinase, putative | 0.0357 | 0.6612 | 1 |
Schistosoma mansoni | sugar transporter | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma cruzi | hexose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Plasmodium vivax | calcium-dependent protein kinase 1, putative | 0.0039 | 0.0597 | 0.0597 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0039 | 0.0597 | 0.2648 |
Leishmania major | myo-inositol/proton symporter (MIT) | 0.0018 | 0.0201 | 0.2874 |
Plasmodium vivax | mitogen-activated protein kinase 2, putative | 0.0204 | 0.3724 | 0.3724 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Trypanosoma cruzi | hexose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Leishmania major | glucose transporter, lmgt1 | 0.0039 | 0.0606 | 0.8651 |
Brugia malayi | Major Facilitator Superfamily protein | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Brugia malayi | Sugar transporter family protein | 0.0126 | 0.2253 | 1 |
Mycobacterium tuberculosis | Lysyl-tRNA synthetase 1 LysS (lysine--tRNA ligase 1) (LysRS 1) (lysine translase) | 0.0024 | 0.0318 | 1 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Entamoeba histolytica | protein kinase, putative | 0.0039 | 0.0597 | 1 |
Trichomonas vaginalis | lysyl-tRNA synthetase, putative | 0.0028 | 0.0399 | 0.1769 |
Toxoplasma gondii | lysine-tRNA ligase | 0.0028 | 0.0399 | 0.0603 |
Leishmania major | prolyl-tRNA synthetase, putative,bifunctional aminoacyl-tRNA synthetase, putative | 0.0044 | 0.0701 | 1 |
Mycobacterium ulcerans | prolyl-tRNA synthetase | 0.0013 | 0.0119 | 0.2978 |
Brugia malayi | Calcium/calmodulin-dependent protein kinase type II alpha chain | 0.0039 | 0.0597 | 0.2648 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Trypanosoma brucei | myo-inositol/proton symporter (MIT) | 0.0018 | 0.0201 | 0.2874 |
Echinococcus granulosus | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | calcium/calmodulin-dependent protein kinase ID | 0.0039 | 0.0597 | 0.2648 |
Echinococcus granulosus | General substrate transporter | 0.0108 | 0.1918 | 0.851 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Plasmodium vivax | hexose transporter | 0.0126 | 0.2253 | 0.2253 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Plasmodium vivax | CDK-related protein kinase 6, putative | 0.0536 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | major facilitator superfamily permease | 0.0018 | 0.0201 | 1 |
Trypanosoma cruzi | prolyl-tRNA synthetase, putative | 0.0044 | 0.0701 | 1 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Echinococcus granulosus | lysyl tRNA synthetase | 0.0028 | 0.0399 | 0.1769 |
Schistosoma mansoni | glutamyl-tRNA synthetase cytoplasmic (glutamate--tRNA ligase) (glurs) | 0.0038 | 0.0582 | 0.2583 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma cruzi | glucose transporter, putative | 0.0018 | 0.0201 | 0.2874 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Plasmodium falciparum | mitogen-activated protein kinase 2 | 0.0204 | 0.3724 | 0.3724 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Brugia malayi | Major Facilitator Superfamily protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Echinococcus granulosus | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Schistosoma mansoni | glucose transport protein | 0.0126 | 0.2253 | 1 |
Mycobacterium ulcerans | sugar-transport integral membrane protein SugI | 0.0018 | 0.0201 | 0.5052 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma brucei | THT1 - hexose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Onchocerca volvulus | Putative transporter | 0.0018 | 0.0201 | 0.5 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0597 | 0.2648 |
Brugia malayi | Cam kinase protein 1 | 0.0039 | 0.0597 | 0.2648 |
Trypanosoma cruzi | hexose transporter | 0.0039 | 0.0606 | 0.8651 |
Plasmodium falciparum | calcium-dependent protein kinase 5 | 0.0039 | 0.0597 | 0.0597 |
Trypanosoma brucei | THT1 - hexose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0448 | 0.1987 |
Mycobacterium ulcerans | integral membrane transport protein | 0.0018 | 0.0201 | 0.5052 |
Toxoplasma gondii | calcium-dependent protein kinase CDPK2A | 0.0039 | 0.0597 | 0.0903 |
Brugia malayi | major facilitator superfamily protein | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Toxoplasma gondii | prolyl-tRNA synthetase (ProRS) | 0.0044 | 0.0701 | 0.106 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Echinococcus multilocularis | Sugar transporter ERD6 protein | 0.0018 | 0.0201 | 0.0894 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Leishmania major | glucose transporter, lmgt2 | 0.0039 | 0.0606 | 0.8651 |
Toxoplasma gondii | calcium-dependent protein kinase CDPK2B | 0.0039 | 0.0597 | 0.0903 |
Toxoplasma gondii | sugar transporter ST1 | 0.0018 | 0.0201 | 0.0305 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Plasmodium falciparum | proline--tRNA ligase | 0.0044 | 0.0701 | 0.0701 |
Echinococcus granulosus | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Leishmania major | lysyl-tRNA synthetase, putative | 0.0028 | 0.0399 | 0.5689 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | glucose transporter, putative | 0.0039 | 0.0606 | 0.269 |
Echinococcus multilocularis | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Plasmodium falciparum | calcium-dependent protein kinase 2 | 0.0039 | 0.0597 | 0.0597 |
Toxoplasma gondii | sugar transporter ST2 | 0.0018 | 0.0201 | 0.0305 |
Entamoeba histolytica | protein kinase, putative | 0.0039 | 0.0597 | 1 |
Schistosoma mansoni | glucose transporter | 0.0018 | 0.0201 | 0.0894 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Schistosoma mansoni | lysyl-tRNA synthetase | 0.0028 | 0.0399 | 0.1769 |
Brugia malayi | major facilitator superfamily protein | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma cruzi | sugar transporter, putative | 0.0018 | 0.0201 | 0.2874 |
Schistosoma mansoni | sugar transporter | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma brucei | calcium/calmodulin-dependent protein kinase, putative | 0.0039 | 0.0597 | 0.8517 |
Mycobacterium ulcerans | lysyl-tRNA synthetase | 0.0028 | 0.0399 | 1 |
Echinococcus granulosus | calcium dependent protein kinase | 0.0036 | 0.0552 | 0.2448 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma brucei | bifunctional aminoacyl-tRNA synthetase, putative | 0.0044 | 0.0701 | 1 |
Loa Loa (eye worm) | bifunctional aminoacyl-tRNA synthetase | 0.0016 | 0.016 | 0.0709 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Plasmodium vivax | sugar transporter, putative | 0.0018 | 0.0201 | 0.0201 |
Plasmodium vivax | calcium-dependent protein kinase, putative | 0.0039 | 0.0597 | 0.0597 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Plasmodium vivax | calcium-dependent protein kinase 3, putative | 0.0039 | 0.0597 | 0.0597 |
Schistosoma mansoni | glucose transport protein | 0.0126 | 0.2253 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0126 | 0.2253 | 1 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0039 | 0.0606 | 0.269 |
Schistosoma mansoni | protein kinase | 0.0039 | 0.0597 | 0.2648 |
Plasmodium falciparum | protein kinase 7 | 0.0357 | 0.6612 | 0.6612 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Trypanosoma brucei | THT1 - hexose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Echinococcus granulosus | synaptic vesicle 2 protein | 0.0018 | 0.0201 | 0.0894 |
Echinococcus granulosus | Sugar transporter ERD6 protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0039 | 0.0606 | 0.269 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0399 | 0.1769 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | myo-inositol transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Mycobacterium tuberculosis | Probable dicarboxylic acid transport integral membrane protein KgtP (dicarboxylate transporter) | 0.0018 | 0.0201 | 0.6328 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Mycobacterium leprae | Probable lysyl-tRNA synthase LysS (lysine--tRNA ligase 1) (LysRS 1) (lysine translase) | 0.0024 | 0.0318 | 0.5469 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Schistosoma mansoni | sugar transporter | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Schistosoma mansoni | glucose transport protein | 0.0126 | 0.2253 | 1 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | prolyl-tRNA synthetase, putative | 0.0038 | 0.0582 | 0.2583 |
Trypanosoma brucei | glucose transporter 1E | 0.0039 | 0.0606 | 0.8651 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Trichomonas vaginalis | sugar transporter, putative | 0.0039 | 0.0606 | 0.269 |
Echinococcus multilocularis | lysyl tRNA synthetase | 0.0028 | 0.0399 | 0.1769 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0126 | 0.2253 | 1 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Mycobacterium leprae | Possible lysyl-tRNA synthetase 2 LysX | 0.0028 | 0.0399 | 0.6849 |
Echinococcus multilocularis | calcium dependent protein kinase | 0.0036 | 0.0552 | 0.2448 |
Loa Loa (eye worm) | sugar transporter | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | glucose transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0582 | 0.2583 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0126 | 0.2253 | 1 |
Schistosoma mansoni | protein kinase | 0.0039 | 0.0597 | 0.2648 |
Entamoeba histolytica | prolyl-tRNA synthetase, putative | 0.0038 | 0.0582 | 0.9752 |
Echinococcus multilocularis | glutamyl tRNA synthetase cytoplasmic | 0.0038 | 0.0582 | 0.2583 |
Schistosoma mansoni | glutamyl-tRNA synthetase cytoplasmic (glutamate--tRNA ligase) (glurs) | 0.0038 | 0.0582 | 0.2583 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Trypanosoma cruzi | prolyl-tRNA synthetase, putative | 0.0044 | 0.0701 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0.0399 | 0.6679 |
Echinococcus granulosus | glutamyl tRNA synthetase cytoplasmic | 0.0038 | 0.0582 | 0.2583 |
Plasmodium falciparum | calcium-dependent protein kinase 3 | 0.0039 | 0.0597 | 0.0597 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Mycobacterium ulcerans | sugar transporter | 0.0018 | 0.0201 | 0.5052 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Leishmania major | prolyl-tRNA synthetase, putative,bifunctional aminoacyl-tRNA synthetase, putative | 0.0044 | 0.0701 | 1 |
Mycobacterium tuberculosis | Probable conserved integral membrane transport protein | 0.0018 | 0.0201 | 0.6328 |
Toxoplasma gondii | calcium-dependent protein kinase CDPK3 | 0.0039 | 0.0597 | 0.0903 |
Leishmania major | protein kinase, putative | 0.0039 | 0.0597 | 0.8517 |
Trypanosoma brucei | glucose transporter 2A | 0.0039 | 0.0606 | 0.8651 |
Plasmodium falciparum | hexose transporter | 0.0126 | 0.2253 | 0.2253 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Plasmodium falciparum | lysine--tRNA ligase | 0.0028 | 0.0399 | 0.0399 |
Echinococcus granulosus | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Schistosoma mansoni | nuclear transcription factor X-box binding 1 (nfx1) | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Giardia lamblia | Sugar-proton symporter | 0.0018 | 0.0201 | 0.346 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase type | 0.0039 | 0.0597 | 0.2648 |
Trypanosoma brucei | lysyl-tRNA synthetase, putative | 0.0028 | 0.0399 | 0.5689 |
Chlamydia trachomatis | lysine--tRNA ligase | 0.0028 | 0.0399 | 1 |
Brugia malayi | lysyl-tRNA synthetase | 0.0028 | 0.0399 | 0.1769 |
Schistosoma mansoni | protein kinase | 0.0039 | 0.0597 | 0.2648 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Chlamydia trachomatis | proline--tRNA ligase | 0.0013 | 0.0119 | 0.2978 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0.0201 | 0.2874 |
Trichomonas vaginalis | sugar transport protein, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0039 | 0.0606 | 0.269 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | CAMK/CAMK2 protein kinase | 0.0039 | 0.0597 | 0.2648 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | lysyl-tRNA synthetase, putative | 0.0025 | 0.0333 | 0.1477 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma cruzi | hexose transporter, putative | 0.0021 | 0.027 | 0.386 |
Trypanosoma cruzi | hexose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma cruzi | hexose transporter, putative | 0.0018 | 0.0201 | 0.2874 |
Giardia lamblia | Lysyl-tRNA synthetase | 0.0028 | 0.0399 | 0.6849 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0039 | 0.0606 | 0.269 |
Echinococcus multilocularis | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | glucose transporter, putative | 0.0039 | 0.0606 | 0.269 |
Loa Loa (eye worm) | sugar transporter | 0.0126 | 0.2253 | 1 |
Plasmodium vivax | calcium-dependent protein kinase 4, putative | 0.0039 | 0.0597 | 0.0597 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Mycobacterium ulcerans | lysyl-tRNA synthetase | 0.0028 | 0.0399 | 1 |
Mycobacterium leprae | Probable prolyl tRNA synthetase ProS | 0.0038 | 0.0582 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0582 | 0.2583 |
Mycobacterium ulcerans | fusion protein of transposase for IS2606 and sialic acid-transport integral membrane protein NanT | 0.0018 | 0.0201 | 0.5052 |
Mycobacterium tuberculosis | Lysyl-tRNA synthetase 2 LysX | 0.0024 | 0.0318 | 1 |
Plasmodium vivax | lysine--tRNA ligase, putative | 0.0028 | 0.0399 | 0.0399 |
Brugia malayi | Bifunctional aminoacyl-tRNA synthetase | 0.0038 | 0.0582 | 0.2583 |
Brugia malayi | Sugar transporter family protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Onchocerca volvulus | 0.0018 | 0.0201 | 0.5 | |
Schistosoma mansoni | serine/threonine protein kinase | 0.0039 | 0.0597 | 0.2648 |
Echinococcus multilocularis | solute carrier family 22 | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma brucei | glucose transporter, putative | 0.0039 | 0.0606 | 0.8651 |
Treponema pallidum | prolyl-tRNA synthetase | 0.0013 | 0.0119 | 1 |
Giardia lamblia | Prolyl-tRNA synthetase | 0.0038 | 0.0582 | 1 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Brugia malayi | Major Facilitator Superfamily protein | 0.0018 | 0.0201 | 0.0894 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Loa Loa (eye worm) | major facilitator superfamily transporter | 0.0018 | 0.0201 | 0.0894 |
Trypanosoma brucei | sugar transporter, putative | 0.0018 | 0.0201 | 0.2874 |
Giardia lamblia | Hexose transporter | 0.0018 | 0.0201 | 0.346 |
Schistosoma mansoni | sugar transporter | 0.0018 | 0.0201 | 0.0894 |
Brugia malayi | bifunctional aminoacyl-tRNA synthetase | 0.0038 | 0.0582 | 0.2583 |
Leishmania major | glucose transporter, lmgt3 | 0.0039 | 0.0606 | 0.8651 |
Echinococcus multilocularis | solute carrier family 2, facilitated glucose | 0.0126 | 0.2253 | 1 |
Leishmania major | glucose transporter/membrane transporter D2, putative | 0.0039 | 0.0606 | 0.8651 |
Trichomonas vaginalis | sugar transporter, putative | 0.0018 | 0.0201 | 0.0894 |
Echinococcus multilocularis | synaptic vesicle 2 protein | 0.0018 | 0.0201 | 0.0894 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence. | ChEMBL. | 22096101 | |
aqueous solubility, where (a) 0 = extremely low, (b) 1 = very low; (c) 2 = low, (d) 3 = good, (e) 4 = optimal, (f) 5 = very soluble (ADMET) | = 2 | aqueous solubility, where (a) 0 = extremely low, (b) 1 = very low; (c) 2 = low, (d) 3 = good, (e) 4 = optimal, (f) 5 = very soluble | Saint Jude. | 20485428 |
CC50 (functional) | = 24.19 uM | Huh7 cytotoxicity for Pf inhibitors | Novartis-GNF Malaria Box. | No reference |
CC50 | = 24.19 uM | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | ChEMBL. | 18579783 |
Compound predicted to be a mutagen in Ames test: 0=false; 1=true (ADMET) | = 0 | TRUE if compound predicted to be a mutagen in an Ames test | Saint Jude. | 20485428 |
EC50 (functional) | = 206 nM | MMV: Inhibition of Plasmodium falciparum K1 (EC50). | ChEMBL. | No reference |
EC50 (functional) | = 746 nM | MMV: Inhibition of Plasmodium falciparum 3D7 (EC50). | ChEMBL. | No reference |
EC50 (functional) | = 0.0964 uM | W2 Pf proliferation inhibition | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 0.0964 uM | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | ChEMBL. | 18579783 |
EC50 (functional) | = 0.24 uM | Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye | Saint Jude. | 20485428 |
EC50 (functional) | 0.2434 uM | ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye | ChEMBL. | 20485428 |
EC50 (functional) | = 0.404 uM | PF proliferation inhibition 3D7 | Novartis-GNF Malaria Box. | No reference |
EC50 (functional) | = 0.404 uM | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | ChEMBL. | 18579783 |
EC50 (functional) | = 0.4403 uM | Differential activity in the presence of antimalarial artemisinin | Saint Jude. | 20485428 |
EC50 (functional) | = 0.7219 uM | Cytotoxic activity for compound versus Plasmodium falciparum K1 | Saint Jude. | 20485428 |
EC50 (functional) | 0.7219 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum K1 | ChEMBL. | 20485428 |
EC50 (functional) | = 0.73 uM | Cytotoxic activity for compound versus Plasmodium falciparum W2 | Saint Jude. | 20485428 |
EC50 (functional) | 0.7324 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum W2 | ChEMBL. | 20485428 |
EC50 (functional) | 0.8976 uM | ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye | ChEMBL. | 20485428 |
EC50 (functional) | = 0.9 uM | Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye | Saint Jude. | 20485428 |
EC50 (functional) | = 1.0156 uM | Differential activity in the presence of antimalarial mefloquine | Saint Jude. | 20485428 |
EC50 (functional) | = 1.1339 uM | Differential activity in the presence of antimalarial chloroquine | Saint Jude. | 20485428 |
EC50 (functional) | 1.3198 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum V1/S | ChEMBL. | 20485428 |
EC50 (functional) | = 1.32 uM | Cytotoxic activity for compound versus Plasmodium falciparum V1/S | Saint Jude. | 20485428 |
EC50 (functional) | = 1.8242 uM | Cytotoxic activity for compound versus Plasmodium falciparum 3D7 | Saint Jude. | 20485428 |
EC50 (functional) | 1.8242 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum 3D7 | ChEMBL. | 20485428 |
EC50 (functional) | = 2.008 uM | Cytotoxic activity for compound versus Plasmodium falciparum Dd2 | Saint Jude. | 20485428 |
EC50 (functional) | 2.008 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum Dd2 | ChEMBL. | 20485428 |
EC50 (functional) | = 2.3572 uM | Differential activity in the presence of antimalarial atovaquone | Saint Jude. | 20485428 |
EC50 (functional) | = 3.4972 uM | Cytotoxic activity for compound versus Plasmodium falciparum SB-A6 | Saint Jude. | 20485428 |
EC50 (functional) | 3.4972 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum SB-A6 | ChEMBL. | 20485428 |
EC50 (functional) | = 3.57 uM | Cytotoxic activity for compound versus Plasmodium falciparum D10 transfected with yeast DHOD | Saint Jude. | 20485428 |
EC50 (functional) | 3.5732 uM | ST_JUDE: Cytotoxicity against Plasmodium falciparum D10 transfected with yeast DHOD | ChEMBL. | 20485428 |
EC50 (functional) | = 9.4886 uM | Cytotoxic activity for compound versus Trypanosoma brucei | Saint Jude. | 20485428 |
EC50 (functional) | = 9.4886 uM | Cytotoxic activity for compound versus Leishmania major | Saint Jude. | 20485428 |
EC50 (functional) | 9.4886 uM | ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of Trypanosoma brucei | ChEMBL. | 20485428 |
EC50 (binding) | > 10 uM | Plasmodium falciparum dihydroorotate dehydrogenase inhibition assay | Saint Jude. | 20485428 |
EC50 (functional) | > 20.08 uM | ST_JUDE: Cytotoxicity using Alamar Blue to measure viability of Leishmania major | ChEMBL. | 20485428 |
EC50 (functional) | = 20.9988 uM | Cytotoxic activity for compound versus human epithelial hepatocellular carcinoma cells | Saint Jude. | 20485428 |
EC50 | 20.9988 uM | ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human epithelial hepatocellular carcinoma cells (HepG2) | ChEMBL. | 20485428 |
EC50 (functional) | > 25.7024 uM | Cytotoxic activity for compound versus Toxoplasma gondii | Saint Jude. | 20485428 |
EC50 (functional) | > 25.7024 uM | ST_JUDE: Growth inhibition of to Toxoplasma gondii, in human U-2OS cells, as measured by luciferase. | ChEMBL. | 20485428 |
EC50 (functional) | = 26 uM | hemozoin polymerization inhibition assay. EC50 from hemozoin assay were approximately derived based on 3 point dose response | Saint Jude. | 20485428 |
EC50 (functional) | > 46.9069 uM | Cytotoxic activity for compound versus human forskin fibroblast cells | Saint Jude. | 20485428 |
EC50 (functional) | > 46.9069 uM | Cytotoxic activity for compound versus human epithelial embryonic kidney cells | Saint Jude. | 20485428 |
EC50 (functional) | > 46.9069 uM | Cytotoxic activity for compound versus human Burkitt's lymphoma lymphoblast cells | Saint Jude. | 20485428 |
EC50 | > 46.9069 uM | ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human epithelial embryonic kidney cells (HEK293) | ChEMBL. | 20485428 |
EC50 | > 46.9069 uM | ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human Burkitt''s lymphoma lymphoblast cells (Raji) | ChEMBL. | 20485428 |
EC50 | > 46.9069 uM | ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human foreskin fibroblast cells (BJ) | ChEMBL. | 20485428 |
EC50 (binding) | > 50 uM | Plasmodium falciparum falcipain 2 inhibition assay | Saint Jude. | 20485428 |
Growth Inhibition (functional) | = 24.0914 % | MMV: Measure of pLDH activity as indication of parasite viability. Gametocytogenesis of 3D7 Plasmodium falciparum strain was induced in vitro and asexual parasites were depleted with N-acetylglucosamine. Gametocytes were treated with dihydroartemisinin, epoxomicin, methylene blue, primaquine, puromycin or chloroquine in 96-well plates and the pLDH activity was evaluated using a modified Makler protocol. Mosquito infectivity was measured by the standard membrane feeding assay. | ChEMBL. | No reference |
IC50 (functional) | = 1699 nM | MMV: IC50 determined against P. falciparum Dd2-luc strain using a Malaria Sybr Green I Fluorescence assay. Starting conditions were 1% trophozoite synchronised parasites at 2% haematocrit. Fluorescence detection completed after 48hr incubation at 37 degrees C under 1% O2, 3% CO2 and balance N2. | ChEMBL. | No reference |
IC50 (functional) | > 12000 nM | ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
IC50 (functional) | > 12000 nM | ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
IC50 (functional) | > 12000 nM | ST_JUDE_LEISH: Cytotoxicity against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
IC50 (functional) | > 1 uM | MMV: PK7 Protein kinase inhibition assay using recombinant PfPK7, ATP and KinaseGlo to measure % inhibition at 1 uM MMV box compound. Final concentrations were 1 uM ATP, 2 mM DTT, 20 mM MgCl2, 2 mM MnCl2, 0.01% BSA, and 6 ug/ml PK7, in a buffer of 20 mM Tris-HCl (pH 7.5). The enzyme itself was the only substrate present (since autophosphorylation occurs); 100 uM 1NA-PP1 was used as a control inhibitor. Incubation time was 3 hours. | ChEMBL. | No reference |
IC50 (functional) | > 1 uM | MMV: MAP2K Protein kinase inhibition assay using recombinant PfMAP2K, protein substrate, ATP and KinaseGlo to measure % inhibition at 1 uM MMV box compound. Final concentrations were 1 uM ATP, 0.5 mM DTT, 1 mM MgCl2, 0.5 mg/mL BSA, and 10 ug/ml MAP2 in a buffer of 50 mM HEPES (pH 7.0). 0.5 mg/mL histone III-S served as the substrate (13); 100 uM AMP-PNP, an ATP analog, was used as a control inhibitor. Incubation time was 4 hours. | ChEMBL. | No reference |
IC50 (functional) | > 1 uM | MMV: PK6 Protein kinase inhibition assay using recombinant PfPK6, Myelin Basic Protein (MBP) substrate, ATP and KinaseGlo to measure % inhibition at 1 uM MMV box compound. Final concentrations were 1.5 uM ATP, 5 mM MnCl2, and 15 ug/ml PK6 in a buffer of 100 mM Tris-HCl (pH 7.5). 50 ug/mL MBP was provided as the substrate; 10 uM staurosporine was used as a control inhibitor. Incubation time was 3 hours and 40 minutes.The catalytic activity of each kinase was considered proportional to ATP consumed, as determined from measurements of residual [ATP] with the luciferase-based reagent Kinase-Glo (Promega) following incubation. Luminescence (proportional to residual [ATP]) was measured on the plate readers FLx800 (BioTek Instruments, Winooski, VT, USA) and MicroBeta2. | ChEMBL. | No reference |
IC50 (functional) | > 1 uM | MMV: CDPK1 Protein kinase inhibition assay using recombinant PfCDPK1, syntide 2 peptide substrate, ATP and KinaseGlo to measure % inhibition at 1 uM MMV box compound. | ChEMBL. | No reference |
IC50 (functional) | > 1 uM | MMV: CDPK4 Protein kinase inhibition assay using recombinant PfCDPK4, syntide2 peptide substrate, ATP and KinaseGlo to measure % inhibition at 1 uM MMV box compound. | ChEMBL. | No reference |
IC50 (functional) | = 1.30346596240997 uM | MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro). | ChEMBL. | No reference |
IC50 (functional) | > 2.5 uM | MMV: ProRS recombinant Plasmodium falciparum Prolyl-tRNA-synthetase, assay with yeast tRNA, ATP, and proline and 3 uM MMV malaria box compound, assay read out with kinase glo as % inhibition. | ChEMBL. | No reference |
IC50 (functional) | > 2.5 uM | MMV: KRS recombinant Plasmodium falciparum Lysyl-tRNA-synthetase, assay with yeast tRNA, ATP, and lysine and 3 uM MMV malaria box compound, assay read out with kinase glo as % inhibition. | ChEMBL. | No reference |
IC50 (functional) | = 2.99927830696106 uM | MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro). | ChEMBL. | No reference |
IC50 (functional) | > 30 uM | MMV: Primary screening was performed with each compound at a 30 uM final concentration and in triplicate in sealed 96-well polystyrene microtiter plates. Parasite inocula (100 ul) comprising 20000 parasites/ml were added to each well and grown at 37 degrees C in a humidified atmosphere of 5% CO2 for 72 h. Positive controls consisted of metronidazole at 1 mg/ml. The growth of E. histolytica trophozoites in each well was determined microscopically by measuring the diameters of the confluent cells in drug-containing wells relative to those in the nega- tive-control wells. | ChEMBL. | No reference |
IC50 (functional) | > 30 uM | MMV: A total of 100ul of inoculum was added to each well (parasite/cell ratio, ~10:1; final volume, 200 ul). Six hours after inoculation, nonadherent parasites were removed, and 100 ul of complete DMEM (1% penicillin-streptomycin, 3% FBS) supplemented with inhibitors at different concentrations (2-fold serial dilutions starting from 30 uM) was added to all except the negative-control wells. Positive controls, consisting of pyrimethamine (PYR) and sulfadiazine (SDZ) (20-mg/ml stocks in DMSO), were tested at a 2mg/ml final concentration. Each test was performed in triplicate. | ChEMBL. | No reference |
IC50 (functional) | > 32 uM | MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro. | ChEMBL. | No reference |
IC50 | > 32 uM | MMV: Cytotoxicity against human fibroblasts (MRC-5) cells. | ChEMBL. | No reference |
IC50 (functional) | > 32 uM | MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro). | ChEMBL. | No reference |
IFI promiscuity index | = 0 | IFI promiscuity index | Novartis-GNF Malaria Box. | No reference |
Inhibition (functional) | = -14.7026563276992 % | MMV: P. falciparum NF54 functionally mature Stage V gametocytes were incubated for 24 hr in the presence of the test compounds. Gamete formation was then triggered by addition of 2uM xantheurenic acid and temperature decrease to ~20C. Female gamete formation was recorded 24 hr later by automated microscopy detection of surface labelling of female gametes with a Cy3-conjugated antibody reactive to Pfs25. All compounds were tested in 4 independent experiments and data presented here is the mean. | ChEMBL. | No reference |
Inhibition (functional) | = -6.67 % | MMV: Screen against Mtb, single point, non replicating, at 25uM | ChEMBL. | No reference |
Inhibition (functional) | = -2.29670197005798 % | MMV: Cryptosporidium parvum oocysts (Iowa Strain) were prepared for use by treatment with 10 mM HCl (37 degrees C, 10 min) followed by 2 mM sodium taurocholate in phosphate-buffered saline (PBS) with Ca2+ and Mg2+ (16 degrees C, 10 min) in order to stimulate excystation. The high-throughput screen was carried out by inoculating >90% confluent human ileocecal adenocarcinoma (HCT-8) cells (ATCC) with ~5.5 x 10^3 primed oocysts per well. Experimental compounds or DMSO (vehicle) were added three hours after infection, and cells were incubated for 48 hours. | ChEMBL. | No reference |
Inhibition (functional) | = -2.2967019700579754 % | MMV: Cryptosporidium parvum oocysts (Iowa Strain) were prepared for use by treatment with 10 mM HCl (37 degrees C, 10 min) followed by 2 mM sodium taurocholate in phosphate-buffered saline (PBS) with Ca2+ and Mg2+ (16 degrees C, 10 min) in order to stimulate excystation. The high-throughput screen was carried out by inoculating >90% confluent human ileocecal adenocarcinoma (HCT-8) cells (ATCC) with ~5.5 x 10^3 primed oocysts per well. Experimental compounds or DMSO (vehicle) were added three hours after infection, and cells were incubated for 48 hours. | ChEMBL. | No reference |
Inhibition (functional) | = 1 % | MMV: Malaria Box compounds were tested for inhibition of the human ether a go-go related gene (hERG), Kv11.1 channel, using IonWorks 384-well patch clamp electrophysiology at 1.1uM (3 independent assay plates up to 12 cells per concentration). | ChEMBL. | No reference |
Inhibition (functional) | = 4.53842974115993 % | MMV: P. falciparum NF54 functionally mature Stage V gametocytes were incubated for 24 hr in the presence of the test compounds. Gamete formation was then triggered by addition of 2uM xantheurenic acid and temperature decrease to ~20C. Male gamete exflagellation was recorded and analysed by automated microscopy after 20 min. All compounds were tested in 4 independent experiments and data presented here is the mean. | ChEMBL. | No reference |
Inhibition (functional) | = 7.45 % | MMV: Screen against Mtb, single point, replicating, at 25uM | ChEMBL. | No reference |
Inhibition (functional) | = 9.630898477856498 % | MMV: P. berghei-infected blood was withdrawn from mice by cardiac pucture before being immediately added to ookinete culture medium containing test compounds. 26 hr later, GFP-positive ookinetes were identified and counted by automated microscopy. All compounds were tested in 4 independent experiments and data presented here is the mean. | ChEMBL. | No reference |
Inhibition (functional) | = 9.6308984778565 % | MMV: P. berghei-infected blood was withdrawn from mice by cardiac pucture before being immediately added to ookinete culture medium containing test compounds. 26 hr later, GFP-positive ookinetes were identified and counted by automated microscopy. All compounds were tested in 4 independent experiments and data presented here is the mean. | ChEMBL. | No reference |
Inhibition (functional) | = 20 % | MMV: Malaria Box compounds were tested for inhibition of the human ether a go-go related gene (hERG), Kv11.1 channel, using IonWorks 384-well patch clamp electrophysiology at 11.1uM (3 independent assay plates up to 12 cells per concentration). | ChEMBL. | No reference |
Inhibition (functional) | = 98 % | MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration. | ChEMBL. | No reference |
LD50 (ADMET) | = 0.525 g kg-1 | rat oral acute median lethal dose (g/kg) | Saint Jude. | 20485428 |
passive intestinal absorption level, where (a) 0 good; (b) 1 = moderate; (c) 2 = poor, (d) 3 = very poor (ADMET) | = 0 | passive intestinal absorption level, where (a) 0 good; (b) 1 = moderate; (c) 2 = poor, (d) 3 = very poor | Saint Jude. | 20485428 |
Percent growth inhibition (functional) | = 90.2 % | Plasmodium falciparum 3D7 % growth inhibition at 7uM as measured by YOYO-3 red dye | Saint Jude. | 20485428 |
Percent growth inhibition (functional) | = 101.8 % | Plasmodium falciparum 3D7 % growth inhibition at 7uM as measured by SYBR green dye | Saint Jude. | 20485428 |
Ratio (functional) | = 1.12280701754386 | MMV: Compounds (1uM) were screened in a 72hr growth assay monitored by flow cytometry both in the presence and absence of supplemental isopentenyl pyrophosphate (IPP) 200uM. Compounds which fail to show anti-malarial activity when chemically rescued by IPP are therefore specific to the apicoplast. The values are expressed as the ratio of the corresponding activity with and without IPP, respectively. | ChEMBL. | No reference |
Relative Growth (functional) | = -0.522 | MMV: Growth assays were conducted using the prototrophic S. cerevisiae strain JHY222. Each MMV compound (0.1 mM) was tested in minimal media containing ethanol and glycerol as carbon sources (Yeast Nitrogen Base, Ethanol, Glycerol; YNBEG). The growth rate in the presence of each MMV compound was calculated as follows: (i) the first 10 OD readings were averaged and subtracted from all OD readings of the corresponding curve to set the baseline of the growth curve to zero, and (ii) the area under the curve (AUC) was then calculated as the sum of all OD readings. AUC was calculated following 180 OD readings, corresponding to roughly 45 h of growth. A relative growth value was calculated as follows: AUC(DRUG) - AUC(DMSO)/AUC(DMSO); where AUC(DMSO) represents growth measured in a DMSO control well that was on the same microtiter plate of the drug-treated culture. A relative growth value near zero means the compound had little or no effect on growth, whereas a value near -1 means the compound strongly or completely inhibited growth. | ChEMBL. | No reference |
Relative Growth (functional) | = -0.0098 | MMV: Growth assays were conducted using the prototrophic S. cerevisiae strain JHY222. Each MMV compound (0.1 mM) was tested in rich media containing dextrose as a carbon source (Yeast Extract, Peptone, Dextrose; YPD). The growth rate in the presence of each MMV compound was calculated as follows: (i) the first 10 OD readings were averaged and subtracted from all OD readings of the corresponding curve to set the baseline of the growth curve to zero, and (ii) the area under the curve (AUC) was then calculated as the sum of all OD readings. AUC was calculated following 80 OD readings corresponding to roughly 20 h of growth. A relative growth value was calculated as follows: AUC(DRUG) - AUC(DMSO)/AUC(DMSO); where AUC(DMSO) represents growth measured in a DMSO control well that was on the same microtiter plate of the drug-treated culture. A relative growth value near zero means the compound had little or no effect on growth, whereas a value near -1 means the compound strongly or completely inhibited growth. | ChEMBL. | No reference |
Relative Growth (functional) | = 0.0319 | MMV: Growth assays were conducted using the prototrophic S. cerevisiae strain JHY222. Each MMV compound (0.1 mM) was tested in minimal media containing dextrose as a carbon source (Yeast Nitrogen Base, Dextrose; YNBD). The growth rate in the presence of each MMV compound was calculated as follows: (i) the first 10 OD readings were averaged and subtracted from all OD readings of the corresponding curve to set the baseline of the growth curve to zero, and (ii) the area under the curve (AUC) was then calculated as the sum of all OD readings. AUC was calculated following 80 OD readings, corresponding to roughly 20 h of growth. A relative growth value was calculated as follows: AUC(DRUG) - AUC(DMSO)/AUC(DMSO); where AUC(DMSO) represents growth measured in a DMSO control well that was on the same microtiter plate of the drug-treated culture. A relative growth value near zero means the compound had little or no effect on growth, whereas a value near -1 means the compound strongly or completely inhibited growth. | ChEMBL. | No reference |
Toxicity (functional) | = 0 | MMV: Toxicity @ 2.5 uM to newly transformed Schistosoma mansoni somules after 24 h on a scale of 0 (none) - 4 (most) as judged visually: includes short descriptors of effects (PMID:19597541). Caffrey group UCSF. | ChEMBL. | No reference |
Toxicity (functional) | = 0 | MMV: Toxicity @ 2.5 uM to newly transformed Schistosoma mansoni somules after 72 h on a scale of 0 (none) - 4 (most) as judged visually: includes short descriptors of effects (PMID:19597541). Caffrey group UCSF. | ChEMBL. | No reference |
Toxicity (functional) | = 1 | MMV: Toxicity @ 2.5 uM to newly transformed Schistosoma mansoni somules after 48 h on a scale of 0 (none) - 4 (most) as judged visually: includes short descriptors of effects (PMID:19597541). Caffrey group UCSF. | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma brucei | ChEMBL23 | 20485428 | |
Plasmodium falciparum | ChEMBL23 | 18579783 | |
Trypanosoma brucei gambiense | 20485428 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.